'Mind and Body': A lifestyle programme for people on antipsychotic medication

Journal of Evaluation in Clinical Practice

Volumn 15, Issue 2, 2009, Pages 276-280

  Jones, Amanda ^a   Benson, Anthony ^a   Griffith, Sarah ^a   Berk, Michael ^a,b,c,d   Dodd, Seetal ^a,b  

^a BARWON HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Antipsychotic medication; Lifestyle program; Mental health

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEALTH STATUS; HUMAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SHORT FORM 36; WELLBEING;

ADULT; ANTIPSYCHOTIC AGENTS; EDUCATION; FEMALE; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MENTAL DISORDERS; MENTAL HEALTH; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES;

EID: 62849101830     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2008.00993.x     Document Type: Article

References (26)

1. Cameron, A. J., Welborn, T. A., Zimmet, P. Z., Dustan, D. W., Owen, N., Salmon, J., Dalton, M., Jolley, D. Shaw, J. E. (2003) Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle study (AusDiab). The Medical Journal of Australia, 178, 427 432.
2. Van Gaal, L. F. (2006) Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity. European Neuropsychopharmacology, 16, S142 S148.
3. De Hert, M., van Eyck, D. De Nayer, A. (2006) Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. International Clinical Psychopharmacology, 21 (Suppl. 2 S11 S15.
4. Green, A. I., Patel, J. K., Goisman, R. M., Allison, D. B. Blackburn, G. (2000) Weight gain from novel antipsychotic drugs: need for action. General Hospital Psychiatry, 22 (4 224 235.
5. Tschoner, A., Engl, J., Laimer, M., Kaser, S., Rettenbacher, M., Fleischhacker, W. W., Patsch, J. R. Ebenbichler, C. F. (2007) Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice, 61 (8 1356 1370.
6. Berk, M., Fitzsimons, J., Lambert, T. (2007) Monitoring the safe use of clozapine: a consensus view from Victoria. Australia CNS Drugs, 21 (2 117 127.
7. McIntyre, R. S., Mancini, D. A. Basile, V. S. (2001) Mechanisms of antipsychotic-induced weight gain. The Journal of Clinical Psychiatry, 62 (Suppl. 23 23 29.
8. Kinon, B. J., Basson, B. R., Gilmore, J. A. Tollefson, G. D. (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. The Journal of Clinical Psychiatry, 62 (2 92 100.
9. Henderson, D. C., Fan, X., Copeland, P. M. (2007) A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatrica Scandinavica, 115 (2 101 105.
10. Henderson, D. C., Copeland, P. M., Daley, T. B. (2005) A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. The American Journal of Psychiatry, 162 (5 954 962.
11. Birt, J. (2003) Management of weight gain associated with antipsychotics. Annals of Clinical Psychiatry, 15, 49 58.
12. Werneke, U., Taylor, D. Sanders, T. A. (2002) Options for pharmacological management of obesity in patients treated with atypical antipsychotics. International Clinical Psychopharmacology, 17, 145 160.
13. Archie, S. M., Goldberg, J. O., Akhtar-Danesh, N., Landeen, J., McColl, L. McNiven, J. (2007) Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatric Services, 58 (2 233 239.
14. Ng, F., Dodd, S. Berk, M. (2007) The effects of physical activity in the acute treatment of bipolar disorder: a pilot study. Journal of Affective Disorders, 101 (1-3 259 262.
15. Evans, S., Newton, R. Higgins, S. (2005) Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. The Australian and New Zealand Journal of Psychiatry, 39, 479 486.
16. Weber, M. Wyne, K. (2006) A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83 (1 95 101.
17. Mauri, M., Castrogiovanni, S., Simoncini, M., Iovieno, N., Miniati, M., Rossi, A., Dell'Agnello, G., Fagiolini, A., Donda, P. Cassano, G. B. (2006) Effects of an educational intervention on weight gain in patients treated with antipsychotics. Journal of Clinical Psychopharmacology, 26 (5 462 466.
18. Kalarchian, M. A., Marcus, M. D., Levine, M. D., Haas, G. L., Greeno, C. G., Weissfeld, L. A. Qin, L. (2005) Behavioral treatment of obesity in patients taking antipsychotic medications. The Journal of Clinical Psychiatry, 66 (8 1058 1063.
19. Pendlebury J., Haddad P. Dursun S. (2005) Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Human Psychopharmacological Clinical and Experimental, 20, 447 448.
20. Goldstein, D. J. (1992) Beneficial health effects of modest weight loss. International Journal of Obesity and Related Metabolic Disorders, 16 (6 397 415.
21. Riebe, D., Blissmer, B., Greene, G., Caldwell, M., Ruggiero, L., Stillwell, K. M. Nigg, C. R. (2005) Long-term maintenance of exercise and healthy eating behaviors in overweight adults. Preventive Medicine, 40 (6 769 778.
22. Muir-Cochrane, E. (2006) Medical co-morbidity risk factors and barriers to care for people with schizophrenia. Journal of Psychiatric and Mental Health Nursing, 13, 47 452.
23. Lambert T. J. R., Chapman L. H., on behalf of the Consensus Working Group (2004) Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. The Medical Journal of Australia, 181 (10 544 548.
24. Garden, G. (2005) Physical examination in psychiatric practice. Advances in Psychiatry Treatment, 11, 142 149.
25. Marder, S. R., Essock, S. M., Miller, A. L. (2004) Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161, 1334 1349.
26. Kinon, B. J., Basson, B. R., Gilmore, J. A. Tollefson, G. D. (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. The Journal of Clinical Psychiatry, 62, 92 100.